Insights

Carrie Koenigsfeld, PharmD, FAPhA, discusses how pharmacists can lead efforts in vaccinating older adults against RSV by addressing barriers to vaccination, integrating education into pharmacy workflows, and implementing community outreach initiatives.

The discussion, led by Kirollos Hanna,PharmD, BCPS, BCOP, FACCC, and Brandon Dyson, PharmD, BCOP, BCPS, focuses on optimizing chronic lymphocytic leukemia care through the management of treatment modifications and adverse events, emphasizing pharmacists’ roles in patient education, dose adjustment strategies, and the economic impact of these modifications.

Sophia Humphreys, PharmD, MHA, BCBBS, explores the role of biosimilars in specialty pharmacy.

Cara Chang, PharmD, BCOP, and Alan Chin, PharmD, BCOP, engage in a comprehensive discussion about EGFR mutation therapies, relevant clinical trials, associated adverse reactions, and crucial strategies for optimizing patient outcomes in this specific subset of NSCLC patients.

Carrie Koenigsfeld, PharmD, FAPhA, provides a comprehensive overview of RSV vaccinations, including current clinical trials, their efficacy and safety data, and emphasizes the importance of addressing vaccine hesitancy by presenting evidence-based information to help patients make informed decisions about receiving the RSV vaccine.

Heather Moore, CPP, PharmD, recaps key topics from the 2023 ASCO meeting surrounding breast cancer treatment.

Ryan Haumschild, PharmD, MS, MBA, provides insights surrounding the utilization of PARP inhibitors and clinical pathways in ovarian cancer treatment.

Expert, Zahra Mahmoudjafari, PharmD, BCOP, DPLA shares insights on the expanding treatment landscape for CLL.

Tim Whitten, BSPharm, MBA, CEO & President of Taiho Oncology Inc discusses the critical impacts of pharmacists across the health care landscape.

Sponsored by Taiho Oncology Inc.

Neal Dave, PharmD, and Brandon Dyson, PharmD, BCOP, BCPS, share insights regarding the treatment landscape for patients with CML and Ph+ ALL.

Prophylactic treatment is critical to treatment management for patients diagnosed with hemophilia A.

Medical experts detail the current and evolving roles of BTK inhibitors in treatment of patients with relapsed/refractory mantle cell lymphoma.

Experts in hematology/oncology share key insight on the treatment of CLL, including the use of BTK inhibitors and the critical role of pharmacists in disease management.

Considerations regarding updates to chronic lymphocytic leukemia treatment algorithms based on novel and emerging therapies presented at the ASH 2021 annual meeting.

Pharmacist and provider perspective on BTK inhibitors for Waldenstrom macroglobulinemia.

Shared insight on unmet needs and recent innovations in the management of marginal zone lymphoma in the relapsed/refractory setting.

Joanna Lewis, PharmD, MBA, discusses practical considerations when selecting over-the-counter medications to treat common conditions pharmacists are often asked about and highlights some recommended medications from the Pharmacy Times’ OTC Guide

Bhavesh Shah, RPh, BCOP; and Thomasina Morris, RPh, MHA, BCOP, discuss the importance of utilizing PARP inhibitors as second-line maintenance therapy in ovarian cancer and share valuable clinical insights.

A discussion on advancements and updates in the treatment of CLL, including the latest research presented at the 2021 American Society of Clinical Oncology Virtual Meeting.